Pauline Juyoux

Pauline Juyoux

Auto-generated profile, based on publicly available information

Pauline Juyoux

Université Grenoble Alpes, CNRS, CEA, EMBL, ISBG, Grenoble, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Science
Verified
Journal Article
Closed access
PJPauline Juyoux
Pauline Juyoux
IGIoannis Galdadas
Ioannis Galdadas
DGDorothea Gobbo
Dorothea Gobbo
JVJill von Velsen
Jill von Velsen
MPMartin Pelosse
Martin Pelosse
MBMatthew W. Bowler
Matthew W. Bowler
The mitogen-activated protein kinase (MAPK) p38α is a central component of signaling in inflammation and the immune response and is, therefore, an important drug target. Little is known about the molecular mechanism of its activation by double phosphorylation from MAPK kinases (MAP2Ks), because of the challenge of trapping a transient and dynamic heterokinase complex. We applied a multidisciplinary approach to generate a structural model of p38α in complex with its MAP2K, MKK6, and to understand the activation mechanism. Integrating cryo–electron microscopy with molecular dynamics simulations, hydrogen-deuterium exchange mass spectrometry, and experiments in cells, we demonstrate a dynamic, multistep phosphorylation mechanism, identify catalytically relevant interactions, and show that MAP2K-disordered amino termini determine pathway specificity. Our work captures a fundamental step of cell signaling: a kinase phosphorylating its downstream target kinase.

12 March 2026 in Science
Verified
Journal Article
Closed access
MFMathis Funk
Mathis Funk
MSMonique I. Spronken
Monique I. Spronken
RHRoy M. Hutchinson
Roy M. Hutchinson
BABenoit Arragain
Benoit Arragain
PJPauline Juyoux
Pauline Juyoux
MRMathilde Richard
Mathilde Richard
Highly pathogenic avian influenza viruses (HPAIVs) derive from H5 and H7 low pathogenic avian influenza viruses (LPAIVs). Although insertion of a furin-cleavable multibasic cleavage site (MBCS) in the hemagglutinin gene was identified decades ago as the genetic basis for the LPAIV-to-HPAIV transition, the mechanisms underlying the occurrence of insertion are unknown. Here, we show that transient H5 RNA structures, predicted to trap the influenza virus polymerase on purine-rich sequences, drive nucleotide insertions, providing empirical evidence of RNA structure involvement in MBCS acquisition. Introduction of H5-like sequences and structures into an H6 hemagglutinin resulted in MBCS-yielding insertions. Our results show that nucleotide insertions that underlie H5 HPAIV emergence result from an RNA structure–driven diversity-generating mechanism, which could also occur in other RNA viruses.

4 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
PJPauline Juyoux
Pauline Juyoux
IGIoannis Galdadas
Ioannis Galdadas
DGDorothea Gobbo
Dorothea Gobbo
JVJill von Velsen
Jill von Velsen
MPMartin Pelosse
Martin Pelosse
MBMatthew W. Bowler
Matthew W. Bowler
The MAP kinase p38α is a central component of signalling in inflammation and the immune response and is, therefore, an important drug target. Little is known about the molecular mechanism of its activation by double-phosphorylation from MAP2Ks, due to the challenge of trapping a transient and dynamic hetero-kinase complex. Here, we applied a multidisciplinary approach to generate the first structure of p38α in complex with its MAP2K MKK6 and understand the activation mechanism. Integrating cryo-EM with MD simulations, HDX-MS and in cellulo experiments, we demonstrate a dynamic, multi-step, phosphorylation mechanism, reveal new catalytically relevant interactions, and show that MAP2K disordered N-termini determine pathway specificity. Our work captures, for the first time, a fundamental step of cell signalling: a kinase phosphorylating its downstream target kinase. One-Sentence Summary: Integrative Cryo-EM and MD analysis of an active hetero-kinase complex reveals details of cellular signal transmission

22 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
PJPauline Juyoux
Pauline Juyoux
JVJill von Velsen
Jill von Velsen
EPErika Pellegrini
Erika Pellegrini
MBMatthew W. Bowler
Matthew W. Bowler
Summary: Kinases are a diverse group of enzymes that use ATP to phosphorylate a variety of substrates. Protein kinases evolved in eukaryotes as important mediators of cell signalling that target specific amino acid side chains to modulate downstream protein function. Among them, the MAPKs (mitogen-activated protein kinases) are a family of intracellular protein kinases that form signalling cascades responding to a number of stimuli, that control fundamental mechanisms such as proliferation, differentiation, inflammation and cell death. Signals propagate through consecutive kinases which eventually phosphorylate and activate a MAPK. Here, we show that the dual specificity threonine/tyrosine MAP kinase kinases (MAP2Ks or MEKs) are able to phosphorylate and activate their substrate MAPKs using ADP as well as ATP in vitro . As the pathways are involved in the stress response, we speculate that it would represent an advantage to be able to maintain signalling under conditions such as hypoxia, that occur under a number of cell stresses, including cancer and atherosclerosis, where the available pool of ATP could be depleted.

19 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JVJill von Velsen
Jill von Velsen
PJPauline Juyoux
Pauline Juyoux
NPNicola Piasentin
Nicola Piasentin
HFHayden Fisher
Hayden Fisher
KLKarine Lapouge
Karine Lapouge
MBMatthew W. Bowler
Matthew W. Bowler
The RAS-RAF-MEK-ERK mitogen-activated protein kinase (MAPK) pathway relays extracellular signals into a cellular response and its dysregulation leads to many pathologies, particularly cancer. Much is known about the individual components of the pathway, however, details of their interactions and how specificity is maintained is still poorly understood. Here, we determined cryo-EM structures of the MAP2K MEK1 activating its substrate MAPK ERK2, the final event in the cascade. We define the molecular details of specificity and activation of ERK2 and examine the mechanism of substrate recognition using solution techniques and molecular dynamics. Binding of the substrate MAPK leads to release of the MAP2K catalytic machinery, a mechanism enhanced in many gain of function disease mutations. Further, we observe that ERK2 release is not required for nucleotide exchange, suggesting how a processive mechanism could proceed. Our data advance the understanding of MAPK signalling specificity and provide a starting point for drug development. One-Sentence Summary: Cryo-EM structures of the MEK1-ERK2 complex reveal details of cellular signal transmission.

27 August 2024 in Thesciencebreaker
Verified
Journal Article
Open access
IGIoannis Galdadas
Ioannis Galdadas
FGFrancesco Luigi Gervasio
Francesco Luigi Gervasio
PJPauline Juyoux
Pauline Juyoux
Phosphorylation is a fundamental mechanism in eukaryotic cells that allows signals to propagate. Kinases orchestrate this process by phosphorylating proteins to modulate their activity. Our work reveals the architecture of the complex between two key players of the mitogen-activated protein kinase signaling pathway, p38α and MKK6, while also giving an idea of what happens when the two come together.